Marked Response to Lu-177 Prostate-Specific Membrane Antigen Treatment in Patient With Metastatic Prostate Cancer

---

Copy For Citation

SOYDAL Ç., ÖZKAN E., AKYÜREK S., KÜÇÜK N. Ö.

CLINICAL NUCLEAR MEDICINE, vol.41, no.2, pp.159-160, 2016 (SCI-Expanded)

• Publication Type: Article / Editorial Material
• Volume: 41 Issue: 2
• Publication Date: 2016
• Doi Number: 10.1097/rlu.0000000000001058
• Journal Name: CLINICAL NUCLEAR MEDICINE
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.159-160
• Keywords: Ga-68-PSMA PET/CT, Lu-177-PSMA treatment, prostatic cancer, INHIBITOR
• Ankara University Affiliated: Yes

Abstract

We present pretreatment Ga-68 prostate-specific membrane antigen (PSMA) PET/CT and posttreatment Lu-177-PSMA whole-body scintigraphy images of a 60-year-old patient with metastatic prostate cancer who is dramatically responding to Lu-177-PSMA treatment.